This announcement is a separate document:
国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司2022年限制性A股股票激励计划回购注销部分限制性股票事项的法律意见书
Legal opinion of Mr. Guo Hao (Shanghai) Firm on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.\'s 2022 restricted A-share incentive plan, repurchase and cancellation of some restricted shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.